-
公开(公告)号:US5919791A
公开(公告)日:1999-07-06
申请号:US998922
申请日:1997-12-29
申请人: Claude Guillonneau , Emile Bisagni , Yves Charton , Ghanem Atassi , Alain Pierre , Stephane Leonce
发明人: Claude Guillonneau , Emile Bisagni , Yves Charton , Ghanem Atassi , Alain Pierre , Stephane Leonce
IPC分类号: A61K31/47 , A61P35/00 , A61P43/00 , C07D471/04 , A01N43/42 , C07D471/00
CPC分类号: C07D471/04
摘要: The compounds of formula: ##STR1## in which: R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and A are as defined in the description, their optical isomers and N-oxides and addition salts thereof with a pharmaceutically acceptable acid or base, and their use as anti-tumour agents.
摘要翻译: 下式的化合物:其中:R1,R2,R3,R4,R5,R6,R7和A如说明书中所定义,它们的光学异构体和N-氧化物及其与药学上可接受的酸或碱的加成盐,以及 它们用作抗肿瘤剂。
-
公开(公告)号:US6162811A
公开(公告)日:2000-12-19
申请号:US999364
申请日:1997-12-29
申请人: Claude Guillonneau , Yves Charton , Emile Bisagni , Ghanem Atassi , Alain Pierre , Nicolas Guilbaud
发明人: Claude Guillonneau , Yves Charton , Emile Bisagni , Ghanem Atassi , Alain Pierre , Nicolas Guilbaud
IPC分类号: A61K31/435 , A61P35/00 , C07D471/04 , A61K31/4745
CPC分类号: C07D471/04
摘要: The compounds of formula: ##STR1## wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7, R.sub.8 and A are as defined in the description, their optical isomers and N-oxides, and pharmaceutically acceptable addition salts thereof with an acid or base, and the use thereof as anti-tumor agents.
摘要翻译: 下式的化合物:其中R1,R2,R3,R4,R5,R6,R7,R8和A如说明书中所定义,它们的光学异构体和N-氧化物及其与酸或碱的药学上可接受的加成盐, 及其作为抗肿瘤剂的用途。
-
公开(公告)号:US5958938A
公开(公告)日:1999-09-28
申请号:US120899
申请日:1998-07-22
IPC分类号: C07D519/00 , A61K31/435 , C07D471/04
CPC分类号: C07D519/00
摘要: Compounds of the formula: ##STR1## in which R.sub.1, R.sub.2, A and B are as defined in the description, their optical isomers, N-oxides and addition salts with a phar-maceutically acceptable acid, and their use as anti-tumor agents.
摘要翻译: 下式的化合物:其中R1,R2,A和B如说明书中所定义,它们的光学异构体,N-氧化物和药学上可接受的酸的加成盐及其作为抗肿瘤剂的用途。
-
公开(公告)号:US6162822A
公开(公告)日:2000-12-19
申请号:US221904
申请日:1998-12-28
申请人: Gilbert Lavielle , Patrick Hautefaye , Ghanem Atassi , Alain Pierre , Laurence Kraus-Berthier , Stephane Leonce
发明人: Gilbert Lavielle , Patrick Hautefaye , Ghanem Atassi , Alain Pierre , Laurence Kraus-Berthier , Stephane Leonce
IPC分类号: C07D221/10 , A61K31/435 , A61K31/47 , A61K31/473 , A61K31/55 , A61P35/00 , C07D209/80 , C07D401/12 , C07D403/12 , C07D519/00 , A01N43/38 , C07D487/00 , C07D487/02 , C07D491/00 , A61R31/40
CPC分类号: C07D209/80 , C09B57/08
摘要: A compound of formula (I) ##STR1## in which: m, and n, which may be identical or different, represent 0 or 1,X and Y, which may be identical or different, represent hydrogen or halogen or alky, trihaloalkyl, alkoxy, hydroxyl, cyano, nitro, amino, alkylamino or dialkylamino,Z represent a linear or branched C.sub.4 to C.sub.12 alkylene chain in which one or more --CH.sub.2 -- are optionally replaced by any one of the following atoms or groups: --NR--, --O--, --S--, --SO--, --SO.sub.2 --, or --CONH--, or by a substituted or unsubstituted heterocylcic,A forms, with two adjacent carbon atoms of the phenyl ring, a phenyl, naphthyl or tetrahydronaphthyl ring or a heterocycle, ##STR2## and medicinal products containing the same are useful as anticancer agent.
摘要翻译: 式(I)化合物,其中m和n可以相同或不同,表示0或1,X和Y可以相同或不同,表示氢或卤素或烷基,三卤代烷基,烷氧基,羟基 ,氰基,硝基,氨基,烷基氨基或二烷基氨基,Z表示直链或支链的C 4至C 12亚烷基链,其中一个或多个-CH 2 - 任选被以下任何一个原子或基团取代:-NR-,-O- ,-S-,-SO-,-SO 2 - 或-CONH-,或通过取代或未取代的杂环A形式与苯环的两个相邻碳原子,苯基,萘基或四氢萘基环或杂环, 含有该药物的药物可用作抗癌剂。
-
公开(公告)号:US5225411A
公开(公告)日:1993-07-06
申请号:US728137
申请日:1991-07-10
IPC分类号: A61K31/505 , A61K31/53 , A61K31/55 , A61P33/00 , A61P35/00 , C07D401/04 , C07D401/12 , C07D403/04
CPC分类号: C07D401/04 , C07D401/12
摘要: The compounds are 2,4-(optionally substituted amino)-6-substituted s.triazines, useful for suppressing the resistance of tumour cells to anti-cancer agents and for suppressing the resistance of parasites to anti-parasitic agents.A compound disclosed is 1-[4,6-bis(allylamino)-2-s-triazinyl]-4-[2,2-bis(p.fluorophenyl)ethylamino]piperidine.
摘要翻译: 这些化合物是2,4-(任选取代的氨基)-6-取代的三嗪,可用于抑制肿瘤细胞对抗癌剂的抗性和抑制寄生虫对抗寄生虫药物的抵抗力。 公开的化合物是1- [4,6-双(烯丙基氨基)-2-s-三嗪基] -4- [2,2-双(对氟苯基)乙基]哌啶。
-
公开(公告)号:US5238936A
公开(公告)日:1993-08-24
申请号:US847916
申请日:1992-03-06
IPC分类号: A61K31/53 , A61P35/00 , C07D251/18 , C07D251/54 , C07D251/70 , C07D401/04 , C07D401/12 , C07D401/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14
CPC分类号: C07D401/04 , C07D251/70 , C07D401/14 , C07D405/14 , C07D407/14 , C07D409/14 , C07D417/14
摘要: The compounds are trisubstituted triazines and pyrimidines useful for the suppressing the resistance of tumour cells to anti-cancer agents and for suppressing the resistance of parasites to anti-parasitic agents.A compound disclosed is 2,4-diallylamino-6-{4-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl) methylamino]piperidin-1-yl}-1,3,5-triazine.
摘要翻译: 这些化合物是可用于抑制肿瘤细胞对抗癌剂的抗性和抑制寄生虫对抗寄生虫药物的抵抗力的三取代三嗪和嘧啶。 公开的化合物是2,4-二烯丙基氨基-6- {4 - [(10,11-二氢-5H-二苯并[a,d]环庚烯-5-基)甲基氨基]哌啶-1-基} 5-三嗪。
-
公开(公告)号:US5854273A
公开(公告)日:1998-12-29
申请号:US899289
申请日:1997-07-23
申请人: Gilbert Lavielle , Patrick Hautefaye , Ghanem Atassi , Alain Pierre , Laurence Kraus-Berthier , Stephane Leonce
发明人: Gilbert Lavielle , Patrick Hautefaye , Ghanem Atassi , Alain Pierre , Laurence Kraus-Berthier , Stephane Leonce
IPC分类号: C07D221/10 , A61K31/435 , A61K31/47 , A61K31/473 , A61K31/55 , A61P35/00 , C07D209/80 , C07D401/12 , C07D403/12 , C07D519/00 , A61K31/40 , C07D403/06
CPC分类号: C07D209/80 , C09B57/08
摘要: A compound of formula (I) ##STR1## in which: X and Y, which may be identical or different, represent hydrogen or halogen or alkyl, trihaloalkyl, alkoxy, hydroxyl, cyano, nitro, amino, alkylamino, or dialkylamino, Z represent a linear or branched C.sub.4 to C.sub.12 alkylene chain in which one or more --CH.sub.2 -- are optionally replaced by any one of the following atoms or groups: --NR--, --O--, --S--, --SO--, --SO.sub.2 --, or --CONH--, A forms, with two adjacent carbon atoms of the phenyl ring, a phenyl, naphthyl or tetrahydronaphthyl ring or a heterocycle, ##STR2## represents any one of the groups as defined in the description, its optical isomers and its addition salts with a pharmaceutically-acceptable acid or base, and medicinal products containing the same which are useful as anticancer agents.
摘要翻译: 式(I)化合物其中:X和Y可以相同或不同,表示氢或卤素或烷基,三卤代烷基,烷氧基,羟基,氰基,硝基,氨基,烷基氨基或二烷基氨基 Z表示直链或支链的C 4至C 12亚烷基链,其中一个或多个-CH 2 - 任选被以下原子或基团中的任何一个取代:-NR - , - O - , - S - , - SO-, - SO 2 - 或-CONH-,A形式,其具有苯环的两个相邻碳原子,苯基,萘基或四氢萘基环或杂环,IMAGE表示说明书中定义的任何一个基团,其旋光异构体 及其与药学上可接受的酸或碱的加成盐,以及含有该盐的药物,可用作抗癌剂。
-
公开(公告)号:US06548515B1
公开(公告)日:2003-04-15
申请号:US09718917
申请日:2000-11-22
申请人: Henri-Philippe Husson , Sylviane Giorgi-Renault , Christophe Tratrat , Ghanem Atassi , Alain Pierre , Pierre Renard , Bruno Pfeiffer
发明人: Henri-Philippe Husson , Sylviane Giorgi-Renault , Christophe Tratrat , Ghanem Atassi , Alain Pierre , Pierre Renard , Bruno Pfeiffer
IPC分类号: A61K314741
CPC分类号: C07D491/04 , C07D219/06 , C07D221/16 , C07D221/18 , C07D491/14 , C07D495/04
摘要: The invention relates to compound of formula (I): wherein: represents a single or double bond, R0 represents hydrogen or hydroxy or alkoxy, R1 and R2, which are identical or different, each represents hydrogen or halogen or alkyl, alkoxy, hydroxy, polyhaloalkyl, nitro or optionally substituted amino or wherein m represents an integer such that 1≦m≦4, or form together with the carbon atoms carrying them an aromatic or non-aromatic, mono- or bi-cyclic group having from 5 to 12 ring members and optionally containing 1 or 2 hetero atoms selected from O, S and N, R3 represents hydrogen or aryl, heteroaryl, cycloalkyl, optionally substituted alkyl or a group of formula COR7 wherein R7 represents aryl, optionally substituted alkyl, optionally substituted amino or OR10 wherein R10 represents aryl or optionally substituted alkyl, X represents oxygen or sulphur or —CH2— or —CH2—CH2—, Ar represents aryl, heteroaryl or arylalkyl, its optical isomers, its hydrates, solvates, and also its addition salts with a pharmaceutically acceptable acid. Medicinal products containing the same are useful in the treatment of cancer.
摘要翻译: 本发明涉及式(I)的化合物:其中:
表示单键或双键,R 0表示氢或羟基或烷氧基,R 1和R 2相同或不同,各自表示氢或卤素或烷基,烷氧基,羟基,多卤代烷基,硝基或任选取代的氨基或 其中m表示1≤= m = 4的整数,或与带有带有5至12个环成员的芳族或非芳族单环或双环基团的碳原子一起形成,并且任选地含有1或 2个选自O,S和N的杂原子,R 3表示氢或芳基,杂芳基,环烷基,任选取代的烷基或式COR7基团,其中R7表示芳基,任选取代的烷基,任选取代的氨基或OR 10,其中R 10表示芳基或任选地 取代的烷基,X表示氧或硫或-CH 2 - 或-CH 2-CH 2 - ,Ar表示芳基,杂芳基或芳基烷基,其光学异构体,其水合物,溶剂合物,以及其与药学上可接受的酸的加成盐。含有它们的医药产品可用于治疗癌症。 -
公开(公告)号:US6071945A
公开(公告)日:2000-06-06
申请号:US361064
申请日:1999-07-26
申请人: Sylvain Rault , Cecile Enguehard , Jean-Charles Lancelot , Max Robba , Ghanem Atassi , Alain Pierre , Daniel-Henri Caignard , Pierre Renard
发明人: Sylvain Rault , Cecile Enguehard , Jean-Charles Lancelot , Max Robba , Ghanem Atassi , Alain Pierre , Daniel-Henri Caignard , Pierre Renard
IPC分类号: A61K31/00 , A61K31/40 , A61K31/407 , A61P35/00 , C07D495/14
CPC分类号: C07D495/14 , Y02P20/55
摘要: A compound selected from those of formula (I): ##STR1## wherein: R.sub.1 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino,R.sub.2 represents optionally substituted aryl or heteroaryl,R.sub.3 represents hydrogen, halogen, alkyl, nitro, hydroxy, alkoxy, trihaloalkyl, trihaloalkoxy or optionally substituted amino,their isomers and addition pharmaceutically-acceptable acid or base salts thereof and medicinal products containing the same are useful in the treatment of cancer.
摘要翻译: 选自式(I)的化合物:其中:R 1表示氢,卤素,烷基,硝基,羟基,烷氧基,三卤代烷基,三卤代烷氧基或任选取代的氨基,R 2表示任选取代的芳基或杂芳基,R 3表示氢, 硝基,羟基,烷氧基,三卤代烷基,三卤代烷氧基或任选取代的氨基,它们的异构体及其加成药学上可接受的酸或碱盐和含有它们的药物可用于治疗癌症。
-
公开(公告)号:US5595976A
公开(公告)日:1997-01-21
申请号:US521189
申请日:1995-08-30
申请人: David Billington , Gilbert Dorey , Pascale Leon , Ghanem Atassi , Alain Pierre , Michael Burbridge , Nicolas Guilbaud
发明人: David Billington , Gilbert Dorey , Pascale Leon , Ghanem Atassi , Alain Pierre , Michael Burbridge , Nicolas Guilbaud
IPC分类号: C07H9/02 , A61K31/70 , A61K31/7028 , A61P9/00 , A61P29/00 , A61P35/00 , C07H9/04 , C07H15/04 , C07H15/10 , C07H15/18 , C07H15/26 , A61K37/00 , C07H3/00
摘要: A compound selected from those of formula (I): ##STR1## in which: A either represents --OR.sub.6, and B represents --CH.sub.2 --X,or, together with B and the carbon atom carrying them, forms an oxygen-containing heterocycle selected from oxirane, 2,2-dimethyl[1,3]dioxolane and [1,3]dioxolan-2-one,and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and X are as defined in the description.
摘要翻译: 选自式(I)的化合物:其中:A表示-OR6,B表示-CH2-X,或者与B和携带它们的碳原子一起形成氧 - 含有杂环的环氧乙烷,2,2-二甲基[1,3]二氧戊环和[1,3]二氧戊环-2-酮,R1,R2,R3,R4,R5,R6和X如说明书中所定义。
-
-
-
-
-
-
-
-
-